ANGELA JEFFERSON: Open Payments
NPI 1275755076 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 21 payments from 8 companies in 2025. Trend: 2023 $684 · 2024 $665 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| 180 Medical, Inc. | 5 | $101 |
| ABBVIE INC. | 4 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $35 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $18 |
Products named: BOTOX, GEMTESA, Nubeqa, GENTLECATH, ERLEADA, Xtandi, JELMYTO, EndoSheath Technology.
Industry payments across MD — which companies pay providers there.
